OCRA
News & Updates
-
Ovarian Cancer Resources & Support
OCRA is committed to offering patients, caregivers and friends the most up to date information about ovarian cancer, helpful resources, and options for support…
-
A Statement from OCRA
If there’s one thing that working toward an end to ovarian cancer has taught us, it’s that life is precious…
-
Speaking Out for Those Who Can’t | OCRA Advocate Leader
In 2005, Denise Lobodinski’s sister Renee was diagnosed with ovarian cancer at the age of 47. That same year, their father was diagnosed with prostate cancer…
-
Survey: Navigating Treatment in the Time of Covid-19
Covid-19 has disrupted nearly every aspect of life as we know it, and navigating a diagnosis and treatment for ovarian cancer – already a game changer – has been impacted as well…
-
Raising Awareness of the Unseen, Giving Voice to the Unheard | Survivor Stories
The world works in ironic and sometimes painful ways Yvette Jives, a nurse and social worker in North Carolina, has spent a lifetime helping others…
-
Niraparib Receives FDA Approval as First-Line Maintenance Therapy for Advanced Ovarian Cancer
(May 4, 2020) On April 29th, the Food and Drug Administration approved niraparib (Zejula, GlaxoSmithKline) as a first-line maintenance treatment for advanced epithelial ovarian, fallopian tube, or…
Help Save Women's Lives
Our Impact
-
Invested over $100M
in ovarian cancer research since 1998
-
Educated 95,000+
future medical professionals since 2002
-
Advocated for $200M+
in government research and education funding in 2019
Fundraise for OCRA
-
Do It Yourself
Create your own unique fundraiser to help end ovarian cancer.
-
Ovarian Cycle
Start or join an Ovarian Cycle® ride in your town and spin for a cure!
Check out our calendar for an upcoming event near you!